Fig. 4From: Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinibKaplan-Meier curves illustrating overall survival (OS) in patients with hepatocellular carcinoma who underwent TACE and apatinib treatment stratified by Up-to-7 criterionBack to article page